Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

A study from the Radcliffe Department of Medicine has found that the Athena SWAN scheme tackles multiple factors more comprehensively than other initiatives.

Circular diagram showing Athena Swan domains

Established in the UK in 2005 to encourage and recognise commitment to advancing the careers of women in science, technology, engineering, maths and medicine, Athena SWAN is now widely adopted in the UK and has spread globally. Despite the widespread adoption of Athena SWAN, there is a paucity of research on the design and implementation of Athena SWAN action plans.

So, a team of researchers from Aarhus University, RDM, and the NIHR Oxford Biomedical Research Centre analysed the design and implementation of 16 departmental Athena SWAN Silver action plans in the Medical Sciences Division of the University of Oxford.

The study showed that Athena SWAN is the single most comprehensive gender equality scheme in Europe. RDM’s Pavel Ovseiko explained: “Given that the complex mix of factors produces barriers for women in science, an equally complex intervention is required to address them. Athena SWAN does this more comprehensively than any other single scheme in Europe by focusing systemic interventions on all genders, career stages, and categories of staff. Yet, Athena SWAN can be further strengthened based on Europe’s best practice of Responsible Research and Innovation in promoting the integration of sex and gender analysis in research and education”.

The study interpreted these empirical findings using complexity theory and showed that Athena SWAN Silver action plans conform to the key considerations of complexity such as having multiple actions and areas of intervention, focusing on the local dynamics, the non-linearity of interventions, and the constantly emerging conditions.

Read the full story on the Radcliffe Department of Medicine website

Find out more about Athena SWAN in the Medical Sciences Division

Similar stories

First trimester placental scan - Artificial Intelligence in Health and Care Award

A first trimester 3D placental ultrasound scan which can predict fetal growth restriction and pre-eclampsia, could become part of a woman's routine care thanks to a new Artificial Intelligence in Health and Care Award.

Impaired antibody response to COVID-19 vaccination in patients with myeloid blood cancers

Oxford researchers have found that antibody responses to the first doses of COVID-19 vaccine in people with chronic myeloid blood cancers are not as strong as those among the general population.

Treating Needle Fears May Reduce COVID-19 Vaccine Hesitancy Rates by 10%

A new large-scale study shows that a quarter of the UK adult population screens positive for a potential injection phobia.

RECOVERY trial Regeneron’s monoclonal antibody combination reduces deaths for hospitalised COVID-19 patients

The Randomised Evaluation of COVID-19 Therapy (RECOVERY) trial has demonstrated that the investigational antibody combination developed by Regeneron reduces the risk of death when given to patients hospitalised with severe COVID-19 who have not mounted a natural antibody response of their own.

Major new study could help protect millions of people with type 2 diabetes from cardiovascular disease

A new study led by the Nuffield Department of Population Health at the University of Oxford will research whether a daily tablet could help protect the millions of people worldwide with type 2 diabetes from developing cardiovascular disease.

Professor Susan Jebb appointed as Chair of the Food Standards Agency

Susan Jebb, Professor of Diet and Population Health in Oxford University’s Nuffield Department of Primary Care Health Sciences, has been appointed as the new Chair of the Food Standards Agency.